Corient Private Wealth’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$438K Buy
+5,865
New +$422K ﹤0.01% 2319
2026
Q1
Sell
-6,234
Closed -$370K 2944
2025
Q4
$370K Buy
6,234
+8
+0.1% +$434 ﹤0.01% 2036
2025
Q3
$344K Buy
6,226
+2
+0% +$104 ﹤0.01% 2039
2025
Q2
$268K Sell
6,224
-837
-12% -$32.3K ﹤0.01% 2059
2025
Q1
$280K Buy
7,061
+246
+4% +$10.9K ﹤0.01% 1890
2024
Q4
$278K Sell
6,815
-4,600
-40% -$192K ﹤0.01% 1937
2024
Q3
$445K Buy
11,415
+6,827
+149% +$272K ﹤0.01% 1803
2024
Q2
$201K Sell
4,588
-204
-4% -$9.86K ﹤0.01% 2116
2024
Q1
$229K Buy
+4,792
New +$215K ﹤0.01% 2030
2023
Q2
Sell
-2,827
Closed -$202K 2130
2023
Q1
$202K Buy
+2,827
New +$224K ﹤0.01% 1799

Other funds holding NGVT

Corient Private Wealth's NGVT Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Ingevity (NGVT) in Q2 2026: 5,865 shares worth $438K. The stake represents ﹤0.01% of the portfolio and ranks #2319 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in NGVT as recently as Q4 2025.

Corient Private Wealth first reported a position in NGVT in Q1 2023 and has held it in 10 quarters since. The position peaked at $445K in Q3 2024. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Corient Private Wealth held 5,865 shares of Ingevity worth $438K as of Q2 2026.
  • Ingevity was a new Corient Private Wealth position in Q2 2026.
  • Ingevity made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2319 holding.
  • Corient Private Wealth first reported a position in Ingevity in Q1 2023 and has held it in 10 quarters since.
  • Corient Private Wealth's Ingevity position peaked at $445K in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.